When COVID-19 restrictions were put into place, many Bay Area residents mourned the sudden loss of the local restaurant scene. But for Julie Murphy, a public health librarian from Emeryville, a severe digestive disorder has long kept her from enjoying…
CISCRP Explores the Impact of COVID-19 on Clinical Research
Patients currently enrolled in ongoing clinical trials for medical conditions other than COVID-19 report experiencing changes as a result of the pandemic such as telemedicine, study medication delivered to their homes, and the use of smartphone apps. BOSTON (PRWEB) MAY…
Hamdard Labs to conduct clinical trials of immunity booster medicines against COVID-19
The company has submitted the proposal for required permission from the concerned authorities and the clinical trial will be conducted at Hamdard Institute of Medical Sciences and Research, New Delhi, Hamdard Laboratories said in a statement. New Delhi: Health and…
Merck in collaboration to develop coronavirus vaccine, with clinical trials to start this year
KEY POINTS U.S. drugmaker Merck plans to work alongside nonprofit scientific research organization IAVI to develop a potential vaccine against the coronavirus. Most experts agree that it could take 12 to 18 months for a safe vaccine to be rolled…
Novavax is latest biotech to begin coronavirus vaccine trial
US biotech Novavax has begun a phase 1 study of its coronavirus vaccine, as the number in clinical development reached double figures. The World Health Organization has been keeping tabs on the various vaccines in development to treat the SARS-CoV-2 coronavirus, and at the latest…
Covis Pharma B.V. Initiates Phase 3 Clinical Trial of Alvesco (Ciclesonide) Inhaler for the Treatment of COVID-19
U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) filing to study the use of Alvesco in COVID-19 Study will evaluate the Safety and Efficacy of Alvesco in the Treatment of Non-hospitalized COVID-19 Patients Aged…
FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients
Phase 3, multicenter U.S. clinical trial utilizing Octagam® 10% will start immediately to evaluate if high-dose IVIG can stabilize or improve patient clinical status PARAMUS, N.J.–(BUSINESS WIRE)– The U.S. Food and Drug Administration (FDA) has approved the investigational new…
FDA aims to thwart infusion pump shortage with new industrywide emergency use authorization
Dive Brief: FDA said Thursday it issued an emergency use authorization to spur availability of infusion pumps as the lifesaving machines and accessories are in short supply for COVID-19 patients. The agency in early April issued guidance targeted at increasing access to…
Philips, startups look to deploy new ultrasound tech amid coronavirus
Dive Brief: Health tech giant Philips and diagnostic imaging startup Caption Health announced FDA clearances this week for ultrasound tools they say could aid healthcare professionals in point-of-care imaging for patients infected with the novel coronavirus. Philips said Wednesday it received…
Clovis steals march on AZ with PARP prostate approval
Shares in US-based Clovis Oncology have ticked up after the biotech became the first to get a PARP class drug approved in prostate cancer. The FDA has approved the company’s Rubraca (rucaparib) as monotherapy for patients with BRCA1/2 mutant castration-resistant disease (mCRPC), after…
